BioSpace News Archive

Amytrx Therapeutics, a mission-driven biopharmaceutical company dedicated to transformative and cutting-edge immune-modulating therapeutics that safely alter the course of chronic inflammatory disorders, announces today it has concluded its $18M in Series A financing with participation from both existing and new investors.

The global exosome diagnostic and therapeutic market size was estimated at $224.34 million in 2020, and is projected to reach $2.9 billion by 2030, growing at a CAGR of 29.4% from 2021 to 2030.

According to QY Research Medical, the global biosurgery market size is projected to reach around US$ 27,324.80 million by 2030 and it is growing at a CAGR of 9.5% from 2021 to 2030.

According to QY Research Medical, the in vitro toxicity testing market size is projected to hit $59,147.6 million by 2030, growing at a CAGR of 12.2% from 2020 to 2030.

The global pharmaceutical glycerine market size was estimated at $89.89 million in 2020, and it is projected to hit around $246.48 million by 2030, growing at a CAGR of 11.2% from 2021 to 2030.

The global Digital Therapeutics Market is forecasted to grow at a rate of 21.6% from USD 223.5 Million in 2020 to USD 1.06 Billion in 2028. It is a subset of digital health.

The Insulin Pumps Market is projected to grow at a rate of 9.30% in terms of value, from 2020 to reach USD 10.25 Billion by 2028.

Increasing incidence of wounds related to chronic diseases such as diabetes, growing global geriatric population, and availability of robust wound care products are some key factors expected to drive Wound Care market growth.

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2022 AACC and AACC Academy Awards.

Agendia, Inc., a commercial-stage company focused on improving outcomes for breast cancer patients worldwide by providing physicians and patients with next-generation diagnostic and information solutions to inform optimized treatment decision-making, today announced 10,000 patients have been successfully enrolled in the FLEX Registry.